Skip to Content
Morningstar

Aurora Cannabis Inc ACB

Morningstar Rating
Unlock
Stock XNAS Rating as of
$6.70 −0.01 (0.15%)
View Full Chart
As of Delayed Price Closed
Unlock our analysis with Morningstar Investor
Start Free Trial

Company Report

View Archive

First Pillar of Germany's Cannabis Legalization Begins April 1; Legal Sales to Come Later

Kristoffer Inton

The Bundestag, the lower house of Germany’s legislature, passed a cannabis bill last month that would allow possession of up to 25 grams and home-growing of up to three plants. The law will become effective April 1 as planned after the Bundesrat, the upper house, voted not to send it to mediation committee on March 22. The law expands on July 1 to allow nonprofit cannabis grow clubs of up to 500 members and 50 grams per member.

Read Full Report

Price vs Fair Value

View History
ACB is trading at a 55% discount.
Price
$7.42
Fair Value
$99.30
Uncertainty
Extreme
1-Star Price
$62.00
5-Star Price
$5.19
Economic Moat
Qpr
Capital Allocation
Dvbk

Bulls Say, Bears Say

Bulls

Aurora is now generating consistent positive adjusted EBITDA, so free cash flow is eventual. The need for dilutive share issuances should fall.

Bears

Aurora has repeatedly issued equity at a massive discount to our fair value estimate, diluting existing shareholders and destroying value. There's a risk it'll do it again.

Show More
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if ACB is a good fit for your portfolio.
Get 7 Days Free

News

View All

Trading Information

Previous Close Price
$6.71
Day Range
$6.67–7.58
52-Week Range
$2.84–11.50
Bid/Ask
$6.66 / $6.70
Market Cap
$365.41 Mil
Volume/Avg
10.1 Mil / 6.5 Mil

Key Statistics

Price/Earnings (Normalized)
—
Price/Sales
1.19
Dividend Yield (Trailing)
—
Dividend Yield (Forward)
—
Total Yield
—

Company Profile

Aurora Cannabis, headquartered in Edmonton, Canada, cultivates and sells medicinal and recreational cannabis through a portfolio of brands that includes Drift, San Rafael '71, Daily Special, Whistler, Being, and Greybeard. Although the company primarily operates in Canada, it has expanded internationally through medical cannabis exporting agreements.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Value
Total Number of Employees
1,130
Website
https://www.auroramj.com

Competitors

Valuation

View More
Metric
ACB
TLRY
CRON
Price/Earnings (Normalized)
 ———
Price/Book Value
 0.820.400.90
Price/Sales
 1.191.6811.31
Price/Cash Flow
 ———
Price/Earnings
ACB
TLRY
CRON

Financial Strength

Metric
ACB
TLRY
CRON
Quick Ratio
 1.790.9621.68
Current Ratio
 3.791.9222.54
Interest Coverage
 —−4.39—
Quick Ratio
ACB
TLRY
CRON

Profitability

Metric
ACB
TLRY
CRON
Return on Assets (Normalized)
 —−13.42%−0.53%
Return on Equity (Normalized)
 —−17.13%−0.55%
Return on Invested Capital (Normalized)
 —−14.23%−4.90%
Return on Assets
ACB
TLRY
CRON
See how this stock stacks up to its competitors with Morningstar Investor
Start Free Trial

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen in Investor
Ticker
Name
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
MKKGY
Merck KGaA ADRPhznsnknKmfksb$70.8 Bil
ZTS
Zoetis Inc Class ANhbkjwvyfNqm$68.9 Bil
HLN
Haleon PLC ADRMbcjcnrvYpsy$37.7 Bil
TEVA
Teva Pharmaceutical Industries Ltd ADRVhplkdbbMryr$14.8 Bil
VTRS
Viatris IncWghbksyhMrkpk$13.6 Bil
RDY
Dr Reddy's Laboratories Ltd ADRJkbvhpnjtKzxd$11.9 Bil
CTLT
Catalent IncXmgzkkzmyWngzyw$10.1 Bil
PRGO
Perrigo Co PLCZbvpzklfZwyk$4.3 Bil
CURLF
Curaleaf Holdings IncVzjcvgtkVcxn$3.6 Bil
PBH
Prestige Consumer Healthcare IncFnwwmhdCznkrz$3.5 Bil

Sponsor Center